Ellington Management Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,900
| Closed | -$607K | – | 787 |
|
|
2019
Q4 | $607K | Buy |
4,900
+1,500
| +44% | +$186K | 0.13% | 115 |
|
|
2019
Q3 | $226K | Buy |
+3,400
| New | +$226K | 0.04% | 434 |
|
|
2019
Q2 | – | Sell |
-7,100
| Closed | -$794K | – | 814 |
|
|
2019
Q1 | $794K | Buy |
+7,100
| New | +$794K | 0.14% | 147 |
|
|
2018
Q3 | – | Sell |
-2,900
| Closed | -$243K | – | 726 |
|
|
2018
Q2 | $243K | Sell |
2,900
-2,200
| -43% | -$184K | 0.02% | 338 |
|
|
2018
Q1 | $314K | Buy |
+5,100
| New | +$314K | 0.02% | 562 |
|
|
2017
Q3 | – | Sell |
-2,300
| Closed | -$278K | – | 902 |
|
|
2017
Q2 | $278K | Sell |
2,300
-300
| -12% | -$36.3K | 0.04% | 419 |
|
|
2017
Q1 | $294K | Buy |
+2,600
| New | +$294K | 0.01% | 464 |
|
|
2016
Q1 | – | Sell |
-2,300
| Closed | -$344K | – | 742 |
|
|
2015
Q4 | $344K | Buy |
+2,300
| New | +$344K | 0.12% | 241 |
|
|
2014
Q2 | – | Sell |
-1,400
| Closed | -$462K | – | 705 |
|
|
2014
Q1 | $462K | Buy |
+1,400
| New | +$462K | 0.14% | 236 |
|